Esperion Therapeutics Inc ESPR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
2.68UNCH (UNCH)
Volume
143,518
Close
2.68quote price arrow up+0.06 (+2.29%)
Volume
7,936,816
52 week range
0.70 - 3.34
Loading...
  • Open2.64
  • Day High2.80
  • Day Low2.54
  • Prev Close2.62
  • 52 Week High3.34
  • 52 Week High Date01/12/24
  • 52 Week Low0.70
  • 52 Week Low Date10/12/23

Key Stats

  • Market Cap495.941M
  • Shares Out185.05M
  • 10 Day Average Volume9.56M
  • Dividend-
  • Dividend Yield-
  • Beta0.83
  • YTD % Change-10.37

KEY STATS

  • Open2.64
  • Day High2.80
  • Day Low2.54
  • Prev Close2.62
  • 52 Week High3.34
  • 52 Week High Date01/12/24
  • 52 Week Low0.70
  • 52 Week Low Date10/12/23
  • Market Cap495.941M
  • Shares Out185.05M
  • 10 Day Average Volume9.56M
  • Dividend-
  • Dividend Yield-
  • Beta0.83
  • YTD % Change-10.37

RATIOS/PROFITABILITY

  • EPS (TTM)-2.11
  • P/E (TTM)-1.27
  • Fwd P/E (NTM)-3.61
  • EBITDA (TTM)-155.399M
  • ROE (TTM)-260.79%
  • Revenue (TTM)116.334M
  • Gross Margin (TTM)62.81%
  • Net Margin (TTM)-179.87%
  • Debt To Equity (MRQ)-57.49%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Esperion Therapeutics Inc

 

Profile

MORE
Esperion Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). The Company's products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company's NEXLETOL and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults...
J. Martin Carroll
Independent Chairman of the Board
Sheldon Koenig
President, Chief Executive Officer, Director
Benjamin Halladay
Chief Financial Officer
Benjamin Looker Esq.
General Counsel
Address
601 21St Street, Suite 300
Vero Beach, FL
32960
United States

Top Peers

SYMBOLLASTCHG%CHG
HROW
Harrow Inc
13.23+0.50+3.93%
SIGA
SIGA Technologies Inc
8.56+0.06+0.71%
AQST
Aquestive Therapeutics Inc
4.26+0.16+3.90%
CDXC
Chromadex Corp
3.48-0.19-5.18%
ALIM
Alimera Sciences Inc
3.90UNCHUNCH